
==== Front
Int J Mol Med
Int J Mol Med
IJMM
International Journal of Molecular Medicine
1107-3756
1791-244X
D.A. Spandidos

10.3892/ijmm.2024.5422
ijmm-54-05-05422
Review
Role of Agrin in tissue repair and regeneration: From mechanisms to therapeutic opportunities (Review)
Li Xiang 12*
Xu Yuan 3*
Si Jing-Xing 1
Gu Fang 4
Ma Ying-Yu 12
1 Center for Plastic and Reconstructive Surgery, Department of Plastic and Reconstructive Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China
2 Key Laboratory of Gastroenterology of Zhejiang Province, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China
3 Department of Gastrointestinal Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo, Zhejiang 315048, P.R. China
4 Department of Paediatrics, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China
Correspondence to: Dr Ying-Yu Ma, Key Laboratory of Gastroenterology of Zhejiang Province, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, 158 Shangtang Road, Hangzhou, Zhejiang 310014, P.R. China, E-mail: mayingyu@hmc.edu.cn
* Contributed equally

11 2024
11 9 2024
11 9 2024
54 5 9805 3 2024
01 8 2024
Copyright: © 2024 Li et al.
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Tissue regeneration is a complex process that involves the recruitment of various types of cells for healing after injury; it is mediated by numerous precise interactions. However, the identification of effective targets for improving tissue regeneration remains a challenge. As an extracellular matrix protein, Agrin plays a critical role in neuromuscular junction formation. Furthermore, recent studies have revealed the role of Agrin in regulating tissue proliferation and regeneration, which contributes to the repair process of injured tissues. An in-depth understanding of the role of Agrin will therefore be of value. Given that repair and regeneration processes occur in various parts of the human body, the present systematic review focuses on the role of Agrin in typical tissue and highlights the potential signaling pathways that are involved in Agrin-induced repair and regeneration. This review offers important insight into novel strategies for the future clinical applications of Agrin-based therapies, which may represent a feasible treatment option for patients who require organ replacement or repair.

Key words

Agrin
repair
regeneration
mechanism
Natural Science Foundation of Zhejiang ProvinceLBY22H180006 LY21H160048 Medical Science and Technology Project of Zhejiang Province2021KY529 2022RC102 This work was supported by the Natural Science Foundation of Zhejiang Province (grant nos. LBY22H180006 and LY21H160048) and the Medical Science and Technology Project of Zhejiang Province (grant nos. 2021KY529 and 2022RC102).
==== Body
pmc1. Introduction

Organ damage and loss are generally caused by congenital abnormalities or acquired disorders. The clinical application of regenerative medicine includes the use of biological products, stem cell therapy, tissue engineering, cellular reprogramming and gene therapy (1). Recently, a regenerative approach, in which the local milieu of the diseased tissue or organ is modulated into a regenerative environment to aid in the healing process, has attracted attention and provided new insights into 'translational medicine'. It is speculated that this approach will replace traditional transplantology in the near future. Thus, this new regenerative approach needs to be explored.

Agrin is an extracellular matrix protein that has heparan sulfate proteoglycan as the core protein. It is encoded by the AGRN gene and has a relative molecular weight of ~220 kDa, including nine protein kinase inhibitor domains, four epidermal growth factor-like domains and one adhesion molecule G homologous domain (2). The AGRN transcript can be spliced to produce different isoforms: Either a type II transmembrane protein or a secreted protein (3) (Fig. 1). This splicing determines both the localization and function of Agrin.

Agrin was originally isolated from tissue with electrical activity. It binds to low-density lipoprotein receptor-related protein 4 (LRP4) and activates muscle-specific kinase (MuSK), thus forming a multiprotein complex at the neuromuscular junction (NMJ) (4). The function of Agrin in the formation and maintenance of the NMJ is relatively well known; however, it also has roles in proliferation, motility, cell adhesion and even the regulation of progression in certain types of cancer (5-7). In a previous study, the role of Agrin in regulating tissue proliferation and regeneration was investigated, revealing that Agrin exerts a pleiotropic therapeutic response, including intrinsic and extrinsic arms, which contributes to the repair process in injured animals (8). Agrin therapy has also been reported to promote both cardiac regeneration after myocardial infarction and the proliferation of human induced pluripotent stem cell-derived cardiomyocytes (9). However, the role of Agrin during tissue repair and regeneration remains largely unknown and investigations are needed to reveal whether Agrin employs a similar strategy to stimulate the proliferation of tissue and organs. In the subsequent sections of the present review, the roles and mechanisms of Agrin in regulating the repair of different tissues and organs were discussed, which may offer important insights into novel strategies for regenerative therapies. The search sequence (PRISMA flow diagram) is provided in Fig. S1.

2. Regulation of Agrin in neurogenesis

Possible mechanisms of Agrin in neurogenesis

Over the last several decades, Agrin has been identified to play a central role in the formation of skeletal neuromuscular synapses between presynaptic motor neurons and postsynaptic muscle fibers (10). During this process, Agrin is released by motor neurons and interacts with the transmembrane LRP4, which leads to acetylcholine receptor (AChR) aggregation via the activation of MuSK; this is important for the formation of a functional NMJ (4).

A previous study demonstrated that local Agrin stimulation induces the clustering of mitochondria and synaptic vesicles, two well-known presynaptic markers, and regulates vesicular trafficking (11). Furthermore, Gautam et al (12) reported that postsynaptic AChR aggregates are significantly reduced in number, size and density in the muscles of Agrin-deficient mutant mice, suggesting that mice lacking Agrin are unable to make synapses. This defect may be caused by the absence of a neuron-specific isoform, with an exon encoding only eight amino acids, which is a critical nerve-derived inducer of postsynaptic differentiation (13). However, two reports have indicated that synapses can form in the absence of Agrin (14,15). Cyclin-dependent kinase 5 is activated by ACh agonists, and is required for the ACh agonist-induced dispersion of AChR clusters that have not been stabilized by Agrin (14). Similarly, a study by Misgeld et al (15) demonstrated that the action of Agrin in vivo is critically dependent on cholinergic neurotransmission. Using double-mutant mice, these authors demonstrated that synapses can form in the absence of Agrin, provided that ACh is also absent. These results suggest that ACh causes instability in newly generated postsynaptic sites and indicate that a major physiological role of Agrin is to counteract this 'anti-synaptogenic' influence (15).

Of note, ectopic MuSK expression promotes ectopic synapse formation, and ectopic MuSK expression stimulates synapse formation in the absence of Agrin and rescues the lethality of AGRN-mutant mice. Furthermore, Agrin ablation is accompanied by a second gene transformation, leading to increased postsynaptic MuSK concentrations. These results further indicate that the postsynaptic cell, and particularly MuSK, has a crucial role in the regulation of synapse formation (16). Furthermore, studies suggest that Agrin may stabilize existing AChR aggregates in the presence of neurally derived dispersants (17,18). Although MuSK and the synapse-specific cytoplasmic protein rapsyn are required in the initial steps of postsynaptic differentiation and the formation of an end-plate band, Agrin is not essential. However, nerve-derived Agrin is required in the subsequent stages of synaptic growth and maintenance (17).

Neurogenesis occurs at every stage of life, including in adults. It has been reported that neurogenesis is associated with learning, memory and mood regulation, and its attenuation contributes to emotional and cognitive deficits during aging and neurological diseases such as Alzheimer's disease (19). In the adult hippocampus, neural stem/progenitor cells of the subgranular zone reorganize and proliferate to generate newborn neurons, which then integrate into the granule cell layer of the dentate gyrus (20). During this dynamic process, the activation and proliferation of quiescent stem cells, neuronal fate specification, cell migration and synaptic integration are all involved (21). In addition, Agrin mRNA levels are reportedly increased in the mouse hippocampus following exposure to an enriched environment, suggesting that Agrin expression is dependent on activity (22). Rather than as a key synaptic organizer, Agrin has been designated as a stabilizer that can induce postsynaptic differentiation in the absence of nerves (17,23). Another study reported that all three members of the Agrin-MuSK-LRP4 complex are involved in the induction of presynaptic differentiation (24), and particularly strong evidence supports the role of LRP4 (25).

During Agrin-induced neurogenesis, multiple types of cells and signaling pathways are involved (26). Transforming growth factor-β1 has been reported to enhance synaptogenesis via the upregulation of neuronal Agrin expression in Schwann cells, which is both sufficient and necessary for mediating synapse-promoting effects in the developing NMJ (27). In addition, Zhang et al (28) revealed that the combined treatment of Agrin and laminin in a co-culture system is able to enhance functional NMJ formation through a primarily neural mechanism, which has potential clinical importance for treating denervation injuries and creating functional neuromuscular constructs for muscle tissue. Zhang et al (22) have also reported that Agrin activates the receptor tyrosine kinase orphan receptor 2 (ROR2) through LRP4 in a mouse model, identifying a role for Agrin-LRP4-ROR2 signaling in adult neurogenesis. Similarly, Ma et al (29) determined the role of Agrin in botulinum neurotoxin type A-induced nerve sprouting in a rat model by regulating downstream MuSK and upstream microRNA (miR)-144, and confirmed that Agrin can regulate nerve sprouting via the miR-144-Agrin-MuSK signaling pathway. Yang et al (23) reported that the expression of the active Agrin isoforms B11 and B19 is upregulated in Schwann cells during nerve regeneration in adults. As well as reporting that neurons express active Agrin, they also noted that glial cells express active Agrin and play a role in inducing AChR clusters beneath perisynaptic Schwann cell sprouts (23), suggesting that Agrin may play an indispensable role in the repair of central nervous system injury.

Possible role of Agrin in nerve disease

Myasthenia gravis (MG) is an autoimmune disease in which antibodies against AChR, MuSK or other AChR-related proteins in the NMJ cause localized or general muscle weakness (30). In patients with MG, autoantibodies bind to the components of postsynaptic muscle endplates and destroy the structure and function of NMJ, thus leading to impaired neuromuscular transmission (31). Recent studies have revealed that antibodies against Agrin and its receptor LRP4 are both critical for NMJ formation and maintenance in patients with MG (32). Furthermore, Yu et al (33) revealed that anti-LRP4/Agrin antibodies in patients with MG are pathogenic; they impair the NMJ by interrupting Agrin-dependent LRP4-MuSK interactions. A multicenter study revealed that LRP4/Agrin antibody-positive patients with double-seronegative MG have more severe clinical disease than antibody-negative patients (34). These results suggest that Agrin-LRP4-MuSK signaling may be a potential therapeutic target for MG and other neuromuscular disorders (35). NT-1654 is a C-terminal fragment of mouse neural Agrin; it possesses the same mechanism of action as Agrin, by binding to LRP4 to activate MuSK protein Docking protein 7 signaling at the NMJ. It has also been demonstrated to induce AChR aggregation and alleviate a sarcopenia-like phenotype (36). Li et al (37) similarly reported that NT-1654 attenuates the clinical severity of this phenotype, effectively promotes AChR aggregation at the NMJ and attenuates the repair of NMJ transmission and the reduction of MuSK in rats with experimental autoimmune MG.

Agrin may also play an important role in other nerve-related diseases. Adult neurogenesis in the hippocampus may represent the plasticity of brain functions, including emotions, learning and memory. A decline in hippocampal neurogenesis is thought to cause emotional and cognitive deficits in aging and Alzheimer's disease. A recent study reported that neurogenesis in the brains of healthy individuals may be more conservative (38,39). Furthermore, Zhang et al (22) revealed that Agrin is upregulated in the hippocampus of mice stimulated by an enriched environment. The genetic deletion of AGRN in excitatory neurons decreases the proliferation of neural stem/progenitor cells and increases depressive-like behavior (22). A further analysis led to a working model in which Agrin activates ROR2 via LRP4 to promote adult neurogenesis.

Sepsis is another infection-induced neuromuscular dysfunction; it can induce denervation-like alterations in the NMJ, which may cause muscle weakness (40). Lv et al (41) reported that decreased Agrin expression may induce skeletal muscle dysfunction in sepsis, whereas exogenous Agrin alleviates neuromuscular dysfunction and downregulates γ- and α7-nicotinic AChR expression.

3. Role of Agrin in the tumor microenvironment

In the process of tumor progression, tumors make new capillaries by angiogenesis, and the targeting of angiogenesis contributes to tumor treatment (42). Localized benign tumors are surrounded by well-developed basement membranes, which limit tumors from migrating from the surrounding tissue into blood vessels. However, in malignant tumors, the tumor triggers an 'angiogenesis switch', thus tipping the balance between pro- and anti-angiogenic factors toward vascularization (43). Angiogenesis is a hallmark of cancer, and although multiple naturally occurring compounds have anti-angiogenic effects, these effects are not absolute (44,45). A recent study demonstrated that different protein modules within proteoglycans can enhance tumor cell plasticity and metastasis (46). However, the molecular mechanisms underlying their recruitment of blood vessels within the tumor niche remain largely elusive.

As a surface proteoglycan, the role of Agrin in promoting cancer angiogenesis has been demonstrated recently (7,47). He et al (47) reported a high expression of Agrin in cholangiocarcinoma tissue compared with that in adjacent non-tumor tissues; further analysis revealed that Agrin expression is associated with poorer prognosis, such as portal vein tumor thrombus and intrahepatic metastasis. Furthermore, forced Agrin expression in cholangiocarcinoma cells appears to promote tumor growth-related processes such as proliferation, colony formation, migration and invasion. In rectal cancer, Agrin expression has also been revealed to be markedly increased, and its upregulation is associated with poor prognosis. However, Agrin inhibition suppresses cell growth in rectal cancer, whereas Agrin overexpression prompts these behaviors in vitro (7). Mechanistically, multiple signaling pathways may participate in Agrin-regulated cancer progression. Agrin reportedly activates the Hippo signaling pathway and induces the translocation of yes-associated protein (YAP) to the nucleus in cholangiocarcinoma (47). However, Agrin also elevates Wnt pathway activity by increasing cyclin D1, c-Myc, phosphorylated glycogen synthase kinase-3β and phosphorylated β-catenin levels (7). These results indicate that Agrin may function as an oncogenic indicator of cancer progression through its activation of various pathways, which may be helpful for developing optimized therapies for cancer.

In the healthy liver, Agrin expression in hepatocytes is minimal and its expression is limited to certain regions surrounding blood vessels. However, during the transformation of liver cirrhosis and hepatocellular carcinoma, Agrin levels in hepatocytes are significantly increased (22). The role of Agrin in extracellular matrix sensing and mechanical conduction has been reported to integrate integrin and focal adhesion, as well as the activation of YAP/tafazzin (TAZ) to promote liver tumor growth (48,49). Furthermore, the depletion of Agrin in cancer cells reduces blood vessel infiltration and suppresses tumor growth, as well as the metastasis of hepatocellular carcinoma cells to mouse lungs. Strikingly, metastatic lesions that can colonize the lungs by Agrin deficiency lack the capacity to attract peripheral pulmonary vessels within these lesions (50).

Endothelial cell recruitment is critical for tumor vascularization. Njah et al (50) demonstrated that Agrin promotes the adherence of endothelial cells to tumor cells by recruiting blood vessels, and then facilitates tumor angiogenesis. Further analysis revealed that Agrin stabilizes vascular endothelial growth factor receptor 2 (VEGFR2) by enhancing its interactions with LRP4-integrin-b1-focal adhesion kinase (FAK) (Fig. 2). This suggests that tumor angiogenesis may be inhibited by targeting Agrin-induced VEGFR2 reductions. Furthermore, by inactivating the Hippo pathway, Agrin can promote extracellular matrix remodeling and stiffness by enhancing YAP/TAZ/transcriptional enhancer associated domain-dependent transcription, which then promotes tumorigenesis (49,51,52). Notably, consistent with other proteoglycans that affect endothelial cell migration, it has been reported that Agrin-either secreted by cancer cells or exogenously supplied - is essential for angiogenesis (53).

In the context of oral squamous cell carcinoma progression, Agrin is upregulated in oral squamous cell carcinoma and promotes cell migration and adhesion, suggesting that Agrin also plays an oncogenic role in oral cancer (54). Agrin can be cleaved through protein hydrolysis to produce bioactive fragments (55). One of the cleavage products is the C-terminal fragment, which reportedly has a role in multiple pathological processes, including sarcopenia (56), renal dysfunction (57) and cancer (58). Rivera et al (59) reported that invasive oral carcinomas have higher Agrin expression than benign tissue. These results suggest that the presence of Agrin may promote cancer progression in the tumor microenvironment. In oral squamous cell carcinoma cells, Agrin can activate FAK by binding to integrins or dystroglycan complexes, and can then induce cell invasion and metastasis through growth factor receptor-bound protein 2, proto-oncogene tyrosine-protein kinase Src, extracellular regulated protein kinases and cyclin D (60,61). Nonetheless, the role of C-terminal fragment Agrin in angiogenesis needs to be further investigated in oral cancer, with a focus on tumor progression.

Other studies have reported that high Agrin expression is also associated with tumor progression and poor prognosis in hepatocellular carcinoma and lung adenocarcinoma (62,63). Agrin-positive staining can be used to identify patients with an increased risk of metastasis after surgery for lung adenocarcinoma, and may therefore be a valuable prognostic marker (62). Furthermore, the recurrence-free survival rate of Agrin-positive patients with hepatocellular carcinoma was reported to be significantly lower than that of Agrin-negative patients (63). The potential mechanism may be the result of Agrin-mediated tumor-related angiogenesis in the tumor microenvironment (53). Furthermore, Agrin knockdown in multiple human endothelial cell lines, including human umbilical vascular, human retinal, human dermal microvascular and human aortic endothelial cells, was observed to be associated with significantly reduced in vitro angiogenesis after treatment with soluble Agrin (50). However, in endothelial cell-specific Agrin knockout mice, normal endothelial and hematopoietic cell development was observed during embryogenesis (64). Of note, the growth of localized or metastatic cancer cells is not affected after their implantation into mice with Agrin-depleted endothelial cells. This finding suggests that Agrin may not play an important role in endothelial development during physiological and tumor-related angiogenesis; targeting endothelial-derived Agrin may therefore not be effective in inhibiting tumor angiogenesis.

Any discrepancies among these studies may be attributed to the availability of Agrin in vitro vs. in vivo, which may rescue the loss of Agrin in endothelial cells in AGRN-knockout mice during tumor angiogenesis. This suggests that in the early stages of tumor growth, endothelial cell recruitment does not require endothelial Agrin, as tumor-derived Agrin can compensate for the endothelial loss of Agrin. Thus, the profiles and mechanisms of Agrin in tumorigenesis need to be further studied.

4. Agrin-mediated cardiac regeneration

At present, heart disease is the leading cause of death world-wide, and repairing the damaged heart remains one of the most critical challenges in cardiovascular disease. In mammals, post-mitotic adult cardiomyocytes lose their proliferative capacity for replenishing damaged tissue (65). Upon injury, cardiomyocytes are replaced by fibrotic tissue, which usually has deleterious consequences. Hypertrophy therefore becomes responsible for most remaining heart growth. Notably, cardiomyocyte proliferation is sufficient for the repair of cardiac injury in neonatal mice; however, this ability is greatly diminished by 1 week after birth (66). In the past decade, however, researchers have questioned whether mature hearts truly lack the ability to produce new myocardium after injury; indeed, their findings suggest the possibility of a substantial endogenous regenerative capacity.

Studies have demonstrated that the proteoglycan Agrin can promote cardiomyocyte proliferation as an extracellular matrix component and is involved in neonatal heart repair (9,67). Of note, Agrin is reportedly enriched in the matrix on postnatal day 1 but decreased by postnatal day 7. Crucially, the administration of recombinant Agrin promotes cardiac regeneration in adult mice after myocardial infarction in vivo through the reactivation of cardiomyocyte proliferation. A porcine model of acute myocardial infarction, which is closely related to human cardiac physiology, has been used to demonstrate that recombinant human Agrin delivered to the infarcted heart can target the affected regions in an efficient and clinically relevant manner. These results indicate that recombinant Agrin may be a novel therapy for acute myocardial infarction and may prevent the onset of chronic heart failure (68). The data obtained from these mouse and porcine models highlight that Agrin treatment may strengthen pleiotropic effects and the broad cardiac repair process.

Agrin has been reported to bind and signal through α-dystroglycan (DAG1) (69) with C-terminus laminin G-like domains (LG1 and LG2) (60,70). In the heart, DAG1 serves as an Agrin receptor that is expressed by cardiomyocytes and mediates mild dedifferentiation and proliferation (9). The aforementioned reports emphasize the potential therapeutic role of Agrin in cardiac repair; this therapy is simple, safe and clinically relevant, and may be used in patients. However, further research is needed regarding the molecular mechanisms, effective dose ranges, toxicity and pharmacokinetics of Agrin.

The results from mouse (9) and porcine (68) myocardial infarction models that received local injections of recombinant Agrin into the damaged heart indicate that Agrin may have an overall cardioprotective effect. This was also accompanied by anti-inflammatory effects and blood vessel production, which adds to cardiomyocyte protection and induces proliferation. These findings suggest that Agrin has the potential to regulate cardiomyocyte cell proliferation. However, epicardial cells with multiple differentiation potential are also of great importance for cardiac regeneration (71). Normal development of the embryonic heart is reportedly regulated by epicardial cells through differentiation and proliferation (72,73). However, it remains unclear whether Agrin can promote the proliferation of embryonic epicardial cells. Jing et al (74) revealed that epicardial cell proliferation is promoted by Agrin through its regulation of YAP activity. Furthermore, YAP is key for the regulation of Hippo signaling (75), and Agrin has been reported to inhibit the Hippo signaling pathway and promote YAP activity (76). Although cardiac dysplasia can be induced by specific exfoliation of the embryonic epicardium (77), the abnormal epithelial-mesenchymal transition, migration and differentiation of epicardial cells can also be induced by proliferation disorders (78,79). The migration and epithelial-mesenchymal transition of epicardial cells are controlled by interactions between epicardial cells and the extracellular matrix (80,81). Thus, Agrin may play an important role in cardiac regeneration through its regulation of epicardial cells.

Considering the various risks and technical issues of current cardiac regenerative strategies, Agrin therapy has potential as a relatively safe and effective drug for repairing damaged hearts. However, caution is needed when performing this cardiac regenerative strategy because of the role of Agrin in tumorigenesis and angiogenesis. Furthermore, to evaluate the potential benefits of therapeutic Agrin, it should be considered whether Agrin can stimulate human cardiac fibroblast hyperproliferation. It would also be worthwhile to investigate whether Agrin has a similar mechanism of action for stimulating cardiomyocyte and cancer cell proliferation.

5. Agrin mediates cartilage formation

Cartilage loss leads to osteoarthritis; cartilage has a low turnover and often fails to repair after injury because it is devoid of blood vessels (82). Cartilage regeneration is therefore a priority in medicine. A study by Erickson et al (83) indicated that AGRN was initially upregulated throughout fracture healing, suggesting that Agrin may have a novel function in non-neural tissue, including cartilage. Consistent with a role for Agrin in skeletal development, a study by Hausser et al (84) demonstrated that Agrin is involved in postnatal skeletal development and endochondral bone formation in transgenic mice. Furthermore, chondrocytes have high Agrin expression in the growth plate, suggesting that the expression of Agrin in cartilage may have a critical role in normal skeletal growth (84).

Agrin is composed of a large N-terminal portion, which binds to components of the basal membrane, and a biologically active C-terminal portion, which contains three globular domains separated by epidermal growth factor-like repeats (85). Eldridge et al (86) reported that Agrin is expressed in a splice isoform without y and z motifs; they also identified Agrin as having strong therapeutic potential in cartilage regeneration. Agrin is expressed in normal cartilage but is progressively lost in osteoarthritis, and Agrin knockdown induces downregulation of the cartilage transcription factor SOX9, as well as other cartilage-specific extracellular matrix molecules. Conversely, cartilage differentiation in vitro and ectopic cartilage formation in vivo are supported by exogenous Agrin. These results suggest that Agrin plays an important role in chondrogenesis and the repair of osteochondral defects (87).

Reduced growth and impaired skeletal development have been observed in Agrin-null mice, thus indicating an important role for Agrin in chondrocyte biology (84). A study by Eldridge et al (87) also revealed that Agrin is upregulated in injured cartilage and induces chondrogenic differentiation in synovial membrane mesenchymal stem cells. A single intra-articular administration of Agrin induces the long-lasting regeneration of critical-size osteochondral defects by attracting joint-resident progenitor cells to the injury site. Furthermore, the simultaneous activation of cAMP responsive element-binding protein and the suppression of canonical Wnt signaling downstream of b-catenin are critical for inducing stable articular chondrocyte differentiation and the formation of stable articular cartilage. In addition, considering the close relationship between cartilage and bone, Agrin may be involved in the replacement of cartilage by bone; this process involves multiple steps and several components of the extracellular matrix (84,86,88,89).

Agrin plays an important role in chondrocyte biology and participates in multiple signal transduction pathways. The Wnt pathway has been well characterized, and is thus an attractive therapeutic target for bone repair and skeletal homeostasis (90). As described in the previous paragraph, β-catenin has various roles at different stages of bone repair and regulates the ratio of osteoblasts and chondrocytes in the callus, which arises from pluripotent mesenchymal stem cells in the early phases after injury (91). Later in the bone healing process, β-catenin induces osteoblast differentiation and osteoblastic matrix production (92). As the main receptor of Agrin, LRP4 is also involved in the modulation of Wnt signal transduction, which is an important pathway in osteogenic differentiation and bone formation (93-95). Souza et al (96) reported that Agrin and its receptors (LRP4 and DAG1) are expressed during the differentiation of osteoblasts from three different sources. Furthermore, Agrin disruption impairs the expression of its receptors, as well as osteoblast differentiation, and treatment with recombinant Agrin slightly improves this process. Agrin knockdown also downregulates the expression of genes related to Wnt and bone morphogenetic protein (BMP) signaling pathways. These results highlight the contribution of the Agrin-Wnt-BMP pathway to osteoblast differentiation and suggest that Agrin is a candidate target in the development of new therapeutic strategies for bone-related diseases and injuries (96).

Together, the aforementioned results indicate that Agrin may be an orchestrator of repair morphogenesis at the joint surface through its modulation of multiple signaling pathways. We therefore anticipate that it represents a unique therapeutic opportunity in the field of osteoarthritis, which opens new avenues of investigation for cartilage-regenerative medicine. However, in the clinic, cartilage defects are often associated with meniscal/ligament injury and are at times accompanied by osteoarthritis. Given that joint instability can be compromised in the presence of inflammation, it remains to be explored whether Agrin can induce cartilage regeneration under these conditions.

6. Role of Agrin in aging and disease

During aging, AChR clusters at the NMJ become fragmented and denervated. As the site of information exchange and storage between motor neurons and muscles, deleterious morphological, functional and molecular features are acquired in the NMJ with advancing age, and the NMJ ultimately degenerates (97). NMJ activity requires communication (through molecular mechanisms) among all three cellular components: The presynapse, postsynapse and postsynaptic currents. These three cellular components collaborate through synapse-associated molecules to regenerate adult NMJs following injuries that cause severed motor axons, postsynaptic current loss and muscle fiber atrophy (98). A study suggested that age-related NMJ decline is induced by compromised Agrin-LRP4-MuSK signaling (99). This highlights the interdependence between all three cellular components of the NMJ, as well as the roles of synapse-associated molecules, such as Agrin, LRP4 and MuSK receptors, in the maintenance and repair of adult NMJs. In this regard, a study has shown that Agrin deletion in a subset of adult motor neurons causes postsynaptic disintegration and motor axon degeneration, suggesting that synaptic molecules-including Agrin-remain essential in adult NMJs (100). This indicates that synaptic molecules that are essential for NMJ formation continue to play important functions in adulthood. Together, these findings suggest that age-related changes in NMJs may be mitigated by targeting these molecules. Studies that have assessed therapeutic potential following injury and in disease have demonstrated that Agrin and other integral components of the NMJ can repair age-related damage. Furthermore, following sciatic nerve crush surgery in young animals, administration of biologically active Agrin fragments into skeletal muscles can accelerate the rate of NMJ remodeling (36).

Sarcopenia is characterized by the loss of skeletal muscle mass, strength and function, and is a strong predictor of multiple adverse health outcomes, such as physical disability, hospitalization and mortality (101,102). During the neuromuscular remodeling process, the neuronal protease neurotrypsin proteolytically cleaves and inactivates AGRN, thus dissociating a 22-kDa C-terminal Agrin fragment (103). Recently, the C-terminal Agrin fragment concentrations in the circulation have emerged as a potential biomarker of skeletal muscle deterioration (104), which may signal the onset of sarcopenia.

Intriguingly, a study has demonstrated that appendicular lean mass, age and sex are significant explanatory factors for C-terminal Agrin fragment concentrations. In male individuals especially, there is a strong correlation between serum C-terminal Agrin concentrations and appendicular lean mass. Furthermore, vitamin D supplementation and physical exercise are significantly associated with lower C-terminal Agrin concentrations (105). This finding indicates that C-terminal Agrin fragments may be a potential marker for identifying sarcopenia in a subgroup of affected individuals in the future. Furthermore, the viability of the C-terminal Agrin fragment as a biomarker for sarcopenia has been confirmed in a variety of subpopulations (106). These results have also revealed that z-Agrin degradation during aging may contribute to NMJ pathology. Pratt et al (107) reported that plasma C-terminal Agrin fragment concentrations are significantly higher in sarcopenic individuals than in nonsarcopenic individuals, suggesting the potential relevance of C-terminal Agrin fragments as an accessible biomarker for skeletal muscle health. Together, these findings indicate that C-terminal Agrin fragments may be used for the diagnosis of sarcopenia, and may also have potential as an early indicator of denervation.

7. Functions of Agrin in other tissue and organs

In tissues such as the kidneys and lungs, Agrin plays a role in mechanotransduction by linking the cell cytoskeleton to other basement membrane components, including DAG1 and laminin-γ1 (108,109), through either direct binding or indirectly via integrins (60). Raats et al (110) concluded that the presence of Agrin in the glomerular capillary wall and its ultrastructural localization are involved in linking the podocyte cytoskeleton to the glomerular basement membrane. However, other studies have directly demonstrated the contribution of Agrin to glomerular basement membrane functionality in podocytes and have reported that the glomerular basement membrane shows normal renal function with no changes in glomerular architecture, suggesting that Agrin is not required for the establishment or maintenance of glomerular basement membrane architecture (111,112). Vestentoft et al (113) reported that the levels of extracellular matrix constituents, including Agrin, are significantly upregulated after rat liver injury, mainly in the second tier of defense. These findings suggest that Agrin may play an important role in the hepatic progenitor cell response process for tissue repair and indicate a potentially important biological role for Agrin in other tissues and organs; however, the detailed roles and mechanisms remain unclear.

Limbal stem cell deficiency is an ocular surface disorder that is caused by the decreased population of corneal epithelial stem or progenitor cells and their dysfunction, which leads to vision loss and corneal blindness (114-116). Corneal epithelium regeneration depends on limbal stem cells, which may contribute to maintaining corneal epithelium homeostasis (117). Hou et al (76) reported that Agrin promotes limbal stem cell proliferation in vitro and noted that Agrin accelerates the wound-healing rate of corneal epithelium by activating limbal stem-cell proliferation in vivo. Further analysis of the underlying mechanism revealed that Agrin can facilitate the nuclear translocation of YAP1 and the expression of cyclin D1 induced by YAP1 dephosphorylation, which subsequently promotes limbal stem cell proliferation (76).

Hematopoiesis is a dynamic process that refers to the production of all hematopoietic-lineage cells generated by multipotent hematopoietic stem cells (118). Among the extracellular matrix components, heparan sulfate proteoglycans reportedly play a crucial role in controlling the structural and functional organization of the bone marrow hematopoietic stem cell niche (119). Agrin is expressed by multipotent nonhematopoietic mesenchymal stem cells as well as by differentiated osteoblasts from the surface of the bone endometrium. Furthermore, Mazzon et al (69) reported that Agrin is a critical niche-derived signal that controls the survival and proliferation of hematopoietic stem cells, and demonstrated that, although Agrin-deficient mice display impaired hematopoiesis, this can be reverted by Agrin-sufficient stroma. These findings suggest that Agrin may play a crucial role in the hematopoietic niche and in the cross-talk between stromal and hematopoietic stem cells.

Wound healing represents a complex biological program for restoring damaged tissue architecture to a normal state (120). During this process, a major factor for effective wound healing following injury is the rate of deposition of new extracellular matrix and its components that favor the healing process, which may subsequently support keratinocyte proliferation, migration and angiogenesis (121). A clinical trial study by Chakraborty et al (122) revealed that the recombinant Agrin fragment has great potential to accelerate wound healing as a bio additive material, and enrichment of the proteoglycan Agrin occurs early in the wound microenvironment, which indicates that it is essential for healing. Importantly, Agrin enhances the actomyosin cables by sensing geometric stress and force after injury, and then completely alters the cytoskeletal structure. Furthermore, matrix metalloproteinase-12 (MMP12) has been identified as a downstream effector of Agrin (123), and the Agrin-MMP12 pathway integrates a broad range of mechanical stimuli to promote optimal mechanical biology for wound healing and the generation of pro-angiogenic parameters. Therefore, injury-triggered Agrin enrichment has been proposed to integrate a broad range of mechanical stimulation and enhanced mechanical sensation through MMP12 activity in keratinocytes, which ultimately favors wound healing.

8. Conclusions and perspectives

Although Agrin was initially identified as a factor that is critical for NMJ function, its function in other tissues-including cardiac regeneration, tumor growth and cartilage formation-implies a widespread role for this protein. Existing evidence suggests that Agrin function is associated with the regulation of tissue proliferation and regeneration. During this process, multiple fundamental signaling pathways that are modulated by Agrin are involved (3,9,22,74,76,86,87,122,124,125) (Table I), and different molecular mechanisms appear to play functional roles in different cell types. For instance, Agrin promotes epithelial-mesenchymal transition by decreasing β-catenin and promoting phosphorylated FAK localization at focal adhesions in human embryonic stem cell-derived epicardial-like cells, and enhances dystroglycan aggregation in the Golgi apparatus. The absence of Agrin leads to the dispersal of dystroglycan in vivo, thus disrupting basement membrane integrity and impairing epithelial-mesenchymal transition. Injury-triggered Agrin enrichment induces a broad range of signaling pathways in different tissues, which ultimately favors the development of an injury microenvironment. In summary, Agrin represents a unique therapeutic opportunity in regenerative medicine, and a new and exciting research avenue involves understanding how to achieve a high specificity of biological effects by regulating otherwise-pleiotropic signaling pathways. However, despite initial findings, the precise function of Agrin in repair and regeneration-at both the molecular and whole-organism levels-remains to be elucidated.

Supplementary Data

Acknowledgements

Not applicable.

Availability of data and materials

Not applicable.

Authors' contributions

YYM conceived the study. XL reviewed the literature and wrote the draft. YX interpreted the information and checked the manuscript. JXS and FG collected part of the information and produced the figures. YYM supervised the preparation of the study and revised the manuscript. All authors read and approved the final manuscript. Data authentication is not applicable.

Ethics approval and consent to participate

Not applicable.

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Abbreviations

LRP4 low density lipoprotein receptor-related protein 4

MuSK muscle-specific kinase

NMJ neuromuscular junction

AChR acetylcholine receptor

NSPCs neural stem/progenitor cells

MG myasthenia gravis

DNMG double-seronegative myasthenia gravis

YAP yes-associated protein

VEGFR2 vascular endothelial growth factor receptor 2

FAK focal adhesion kinase

ERK extracellular regulated protein kinases

CREB cAMP responsive element binding protein

BMP bone morphogenetic protein

MMP12 matrix metalloproteinase-12

Figure 1 Schematic showing different forms of Agrin. Referenced by Chakraborty et al (3) and recreated with BioRender.com. AChR, acetylcholine receptor.

Figure 2 Agrin promotes adherence of endothelial cells to tumor cells and enhances tumor angiogenesis. The primary mechanism is extracellular matrix stiffness and Agrin stabilizes VEGFR2 by enhancing interactions with LRP4-Integrin-b1-FAK. Referenced by Njah et al (50) and recreated with BioRender.com. LRP4, low-density lipoprotein receptor-related protein 4, FAK, focal adhesion kinase; ECM, extracellular matrix.

Table I Signaling network during Agrin-induced regeneration.

Author(s), year	Cell type	Function	Targets	Mechanism	(Refs.)	
Bassat et al, 2017	Cardiomyocyte	Promotes division	DGC/YAP	Disassembly of the DGC, and Yap- and ERK-mediated signalling	(9)	
Zhang et al, 2019	NSPCs	Neurogenesis	LRP4/Ror2	Promotes adult neurogenesis through proliferation and maturation of NSPCs	(22)	
Jing et al, 2021	Epicardial Cells	Promotes proliferation	YAP	Increases the expression of Ki67, pH3 and Aurora B through YAP	(74)	
Hou et al, 2020	Limbal stem cells	Promotes proliferation	YAP/Cyclin D1	Facilitates the dephosphorylation of Yap1 and activates transcription of Cyclin D1	(76)	
Eldridge et al, 2016	Chondrocyte	Differentiation	LRP4/DAG/DKK1	Inhibition of WNT pathway and promotion of SOX9 expression	(86)	
Eldridge et al, 2020	Chondrocyte	Differentiation	LRP4/DAG/CaMKII	Inhibition of WNT signaling in a CREB-dependent manner	(87)	
Chakraborty et al, 2021	Keratinocytes	Enhances mechanically competent	MMP-12	Overhauls cytoskeletal architecture via enhancing actomyosin cables	(122)	
Chakraborty et al, 2018; Calvo et al, 2013	Cancer cell	Carcinogenesis	MuSK	Inhibition of the Hippo pathway by promoting the FAK-ILK-PAK1 axis	(3,124)	
Sun et al, 2021	Epicardial cells	Regulator of EMT	β-catenin/pFAK	Enhances EMT by decreasing β-catenin and promoting pFAK localization and the aggregation of dystroglycan	(125)	
LRP4, low-density lipoprotein receptor-related protein 4, DKK1, dickkopf WNT signaling pathway inhibitor 1; DAG, dystroglycan; FAK-ILKPAK1, focal adhesion kinase-integrin linked kinase-p21 activated kinase; CaMKII, calcium/calmodulin-dependent protein kinase II; DGC, dystrophin-glycoprotein complex; Musk, muscle-associated receptor tyrosine kinase; NSPCs, neural stem/progenitor cells; YAP, yes-associated protein; EMT, epithelial-mesenchymal transition.
==== Refs
References

1 Mao AS Mooney DJ Regenerative medicine: Current therapies and future directions Proc Natl Acad Sci USA 112 14452 14459 2015 10.1073/pnas.1508520112 26598661
2 Tsim KW Ruegg MA Escher G Kroger S McMahan UJ cDNA that encodes active agrin Neuron 8 677 689 1992 10.1016/0896-6273(92)90089-V 1314620
3 Chakraborty S Hong W Linking extracellular matrix agrin to the hippo pathway in liver cancer and beyond Cancers (Basel) 10 45 2018 10.3390/cancers10020045 29415512
4 Xie T Xu G Liu Y Quade B Lin W Bai XC Structural insights into the assembly of the agrin/LRP4/MuSK signaling complex Proc Natl Acad Sci USA 120 e2300453120 2023 10.1073/pnas.2300453120 37252960
5 Adamiok-Ostrowska A Grzanka M Czarnocka B Agrin is a novel oncogenic protein in thyroid cancer Oncol Lett 26 483 2023 10.3892/ol.2023.14070 37818129
6 Han L Shi H Ma S Luo Y Sun W Li S Zhang N Jiang X Gao Y Huang Z Agrin promotes non-small cell lung cancer progression and stimulates regulatory T cells via increasing IL-6 secretion through PI3K/AKT pathway Front Oncol 11 804418 2022 10.3389/fonc.2021.804418 35111682
7 Wang ZQ Sun XL Wang YL Miao YL Agrin promotes the proliferation, invasion and migration of rectal cancer cells via the WNT signaling pathway to contribute to rectal cancer progression J Recept Signal Transduct Res 41 363 370 2021 10.1080/10799893.2020.1811325 32862766
8 Sarig R Rimmer R Bassat E Zhang L Umansky KB Lendengolts D Perlmoter G Yaniv K Tzahor E Transient p53-mediated regenerative senescence in the injured heart Circulation 139 2491 2494 2019 10.1161/CIRCULATIONAHA.119.040125 31107623
9 Bassat E Mutlak YE Genzelinakh A Shadrin IY Baruch Umansky K Yifa O Kain D Rajchman D Leach J Riabov Bassat D The extracellular matrix protein agrin promotes heart regeneration in mice Nature 547 179 184 2017 10.1038/nature22978 28581497
10 Li L Xiong WC Mei L Neuromuscular junction formation, aging, and disorders Annu Rev Physiol 80 159 188 2018 10.1146/annurev-physiol-022516-034255 29195055
11 Oentaryo MJ Tse AC Lee CW Neuronal MT1-MMP mediates ECM clearance and Lrp4 cleavage for agrin deposition and signaling in presynaptic development J Cell Sci 133 jcs246710 2020 10.1242/jcs.246710 32591486
12 Gautam M Noakes PG Moscoso L Rupp F Scheller RH Merlie JP Sanes JR Defective neuromuscular synaptogenesis in agrin-deficient mutant mice Cell 85 525 535 1996 10.1016/S0092-8674(00)81253-2 8653788
13 Burgess RW Nguyen QT Son YJ Lichtman JW Sanes JR Alternatively spliced isoforms of nerve- and muscle-derived agrin: Their roles at the neuromuscular junction Neuron 23 33 44 1999 10.1016/S0896-6273(00)80751-5 10402191
14 Lin W Dominguez B Yang J Aryal P Brandon EP Gage FH Lee KF Neurotransmitter acetylcholine negatively regulates neuromuscular synapse formation by a Cdk5-dependent mechanism Neuron 46 569 579 2005 10.1016/j.neuron.2005.04.002 15944126
15 Misgeld T Kummer TT Lichtman JW Sanes JR Agrin promotes synaptic differentiation by counteracting an inhibitory effect of neurotransmitter Proc Natl Acad Sci USA 102 11088 11093 2005 10.1073/pnas.0504806102 16043708
16 Kim N Burden SJ MuSK controls where motor axons grow and form synapses Nat Neurosci 11 19 27 2008 10.1038/nn2026 18084289
17 Lin W Burgess RW Dominguez B Pfaff SL Sanes JR Lee KF Distinct roles of nerve and muscle in postsynaptic differentiation of the neuromuscular synapse Nature 410 1057 1064 2001 10.1038/35074025 11323662
18 Yang X Arber S William C Li L Tanabe Y Jessell TM Birchmeier C Burden SJ Patterning of muscle acetylcholine receptor gene expression in the absence of motor innervation Neuron 30 399 410 2001 10.1016/S0896-6273(01)00287-2 11395002
19 Grabrucker S Marizzoni M Silajdzic E Lopizzo N Mombelli E Nicolas S Dohm-Hansen S Scassellati C Moretti DV Rosa M Microbiota from Alzheimer's patients induce deficits in cognition and hippocampal neurogenesis Brain 146 4916 4934 2023 10.1093/brain/awad303 37849234
20 Goncalves JT Schafer ST Gage FH Adult neurogenesis in the hippocampus: From stem cells to behavior Cell 167 897 914 2016 10.1016/j.cell.2016.10.021 27814520
21 Ming GL Song H Adult neurogenesis in the mammalian brain: Significant answers and significant questions Neuron 70 687 702 2011 10.1016/j.neuron.2011.05.001 21609825
22 Zhang H Sathyamurthy A Liu F Li L Zhang L Dong Z Cui W Sun X Zhao K Wang H Agrin-Lrp4-Ror2 signaling regulates adult hippocampal neurogenesis in mice Elife 8 e45303 2019 10.7554/eLife.45303 31268420
23 Yang JF Cao G Koirala S Reddy LV Ko CP Schwann cells express active agrin and enhance aggregation of acetylcholine receptors on muscle fibers J Neurosci 21 9572 9584 2001 10.1523/JNEUROSCI.21-24-09572.2001 11739568
24 Yu J Oentaryo MJ Lee CW Local protein synthesis of neuronal MT1-MMP for agrin-induced presynaptic development Development 148 dev199000 2021 10.1242/dev.199000 34015092
25 Uyen Dao TM Barbeau S Messeant J Della-Gaspera B Bouceba T Semprez F Legay C Dobbertin A The collagen ColQ binds to LRP4 and regulates the activation of the Muscle-Specific Kinase-LRP4 receptor complex by agrin at the neuromuscular junction J Biol Chem 299 104962 2023 10.1016/j.jbc.2023.104962 37356721
26 Gao H Zhao Z Li J Guo Z Zhang F Wang K Bai X Wang Q Guan Y Wang Y Platelet-rich plasma promotes skeletal muscle regeneration and neuromuscular functional reconstitution in a concentration-dependent manner in a rat laceration model Biochem Biophys Res Commun 672 185 192 2023 10.1016/j.bbrc.2023.05.123 37354612
27 Feng Z Ko CP Schwann cells promote synaptogenesis at the neuromuscular junction via transforming growth factor-beta1 J Neurosci 28 9599 9609 2008 10.1523/JNEUROSCI.2589-08.2008 18815246
28 Zhang BG Quigley AF Bourke JL Nowell CJ Myers DE Choong PF Kapsa RM Combination of agrin and laminin increase acetylcholine receptor clustering and enhance functional neuromuscular junction formation In vitro Dev Neurobiol 76 551 565 2016 10.1002/dneu.22331 26251299
29 Ma L Pan L Liu W Liu Y Xiang X Pan Y Zhang X Jin L Agrin influences botulinum neurotoxin a-induced nerve sprouting via miR-144-agrin-MuSK signaling Front Cell Dev Biol 8 15 2020 10.3389/fcell.2020.00015 32083076
30 Gilhus NE Tzartos S Evoli A Palace J Burns TM Verschuuren JJGM Myasthenia gravis Nat Rev Dis Primers 5 30 2019 10.1038/s41572-019-0079-y 31048702
31 Lazaridis K Tzartos SJ Autoantibody specificities in myasthenia gravis; implications for improved diagnostics and therapeutics Front Immunol 11 212 2020 10.3389/fimmu.2020.00212 32117321
32 Yan M Xing GL Xiong WC Mei L Agrin and LRP4 antibodies as new biomarkers of myasthenia gravis Ann N Y Acad Sci 1413 126 135 2018 10.1111/nyas.13573 29377176
33 Yu Z Zhang M Jing H Chen P Cao R Pan J Luo B Yu Y Quarles BM Xiong W Characterization of LRP4/agrin antibodies from a patient with myasthenia gravis Neurology 97 e975 e987 2021 10.1212/WNL.0000000000012463 34233932
34 Rivner MH Quarles BM Pan JX Yu Z Howard JF Jr Corse A Dimachkie MM Jackson C Vu T Small G Clinical features of LRP4/agrin-antibody-positive myasthenia gravis: A multicenter study Muscle Nerve 62 333 343 2020 10.1002/mus.26985 32483837
35 Ohno K Ohkawara B Ito M Agrin-LRP4-MuSK signaling as a therapeutic target for myasthenia gravis and other neuromuscular disorders Expert Opin Ther Targets 21 949 958 2017 10.1080/14728222.2017.1369960 28825343
36 Hettwer S Lin S Kucsera S Haubitz M Oliveri F Fariello RG Ruegg MA Vrijbloed JW Injection of a soluble fragment of neural agrin (NT-1654) considerably improves the muscle pathology caused by the disassembly of the neuromuscular junction PLoS One 9 e88739 2014 10.1371/journal.pone.0088739 24520420
37 Li Z Li M Wood K Hettwer S Muley SA Shi FD Liu Q Ladha SS Engineered agrin attenuates the severity of experimental autoimmune myasthenia gravis Muscle Nerve 57 814 820 2018 10.1002/mus.26025 29193204
38 Kempermann G Gage FH Aigner L Song H Curtis MA Thuret S Kuhn HG Jessberger S Frankland PW Cameron HA Human adult neurogenesis: Evidence and remaining questions Cell Stem Cell 23 25 30 2018 10.1016/j.stem.2018.04.004 29681514
39 Sorrells SF Paredes MF Cebrian-Silla A Sandoval K Qi D Kelley KW James D Mayer S Chang J Auguste KI Human hippocampal neurogenesis drops sharply in children to undetectable levels in adults Nature 555 377 381 2018 10.1038/nature25975 29513649
40 Li X Sun B Li J Ye W Li M Guan F Wu S Luo X Feng J Jia J Sepsis leads to impaired mitochondrial calcium uptake and skeletal muscle weakness by reducing the micu1: Mcu protein ratio Shock 60 698 706 2023 10.1097/SHK.0000000000002221 37695737
41 Lv B Min S Xie F Yang J Chen J Alleviating sepsis-induced neuromuscular dysfunction linked with acetylcholine receptors by agrin J Surg Res 241 308 316 2019 10.1016/j.jss.2019.04.017 31055156
42 Abdalla A Murali C Amin A Safranal inhibits angiogenesis via targeting HIF-1α/VEGF machinery: In vitro and Ex vivo insights Front Oncol 11 789172 2022 10.3389/fonc.2021.789172 35211395
43 Hanahan D Folkman J Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 353 364 1996 10.1016/S0092-8674(00)80108-7 8756718
44 Abdalla Y Abdalla A Hamza AA Amin A Safranal prevents liver cancer through inhibiting oxidative stress and alleviating inflammation Front Pharmacol 12 777500 2022 10.3389/fphar.2021.777500 35177980
45 Bouabdallah S Al-Maktoum A Amin A Steroidal saponins: Naturally occurring compounds as inhibitors of the hallmarks of cancer Cancers (Basel) 15 3900 2023 10.3390/cancers15153900 37568716
46 Wiedmann L De Angelis Rigotti F Vaquero-Siguero N Donato E Espinet E Moll I Alsina-Sanchis E Bohnenberger H Fernandez-Florido E Mulfarth R HAPLN1 potentiates peritoneal metastasis in pancreatic cancer Nat Commun 14 2353 2023 10.1038/s41467-023-38064-w 37095087
47 He M Cheng C Tu J Ji SS Lou D Bai B Agrin expression is correlated with tumor development and poor prognosis in cholangiocarcinoma J Int Med Res 49 3000605211009722 2021 10.1177/03000605211009722 34018826
48 Chakraborty S Lakshmanan M Swa HL Chen J Zhang X Ong YS Loo LS Akincilar SC Gunaratne J Tergaonkar V An oncogenic role of agrin in regulating focal adhesion integrity in hepatocellular carcinoma Nat Commun 6 6184 2015 10.1038/ncomms7184 25630468
49 Chakraborty S Njah K Pobbati AV Lim YB Raju A Lakshmanan M Tergaonkar V Lim CT Hong W Agrin as a mechanotransduction signal regulating YAP through the hippo pathway Cell Rep 18 2464 2479 2017 10.1016/j.celrep.2017.02.041 28273460
50 Njah K Chakraborty S Qiu B Arumugam S Raju A Pobbati AV Lakshmanan M Tergaonkar V Thibault G Wang X Hong W A role of agrin in maintaining the stability of vascular endothelial growth factor receptor-2 during tumor angiogenesis Cell Rep 28 949 965.e7 2019 10.1016/j.celrep.2019.06.036 31340156
51 Bordeleau F Mason BN Lollis EM Mazzola M Zanotelli MR Somasegar S Califano JP Montague C LaValley DJ Huynh J Matrix stiffening promotes a tumor vasculature phenotype Proc Natl Acad Sci USA 114 492 497 2017 10.1073/pnas.1613855114 28034921
52 Frye M Taddei A Dierkes C Martinez-Corral I Fielden M Ortsater H Kazenwadel J Calado DP Ostergaard P Salminen M Matrix stiffness controls lymphatic vessel formation through regulation of a GATA2-dependent transcriptional program Nat Commun 9 1511 2018 10.1038/s41467-018-03959-6 29666442
53 Chakraborty S Njah K Hong W Agrin mediates angiogenesis in the tumor microenvironment Trends Cancer 6 81 85 2020 10.1016/j.trecan.2019.12.002 32061308
54 Kawahara R Granato DC Carnielli CM Cervigne NK Oliveria CE Rivera C Yokoo S Fonseca FP Lopes M Santos-Silva AR Agrin and perlecan mediate tumorigenic processes in oral squamous cell carcinoma PLoS One 9 e115004 2014 10.1371/journal.pone.0115004 25506919
55 Neill T Schaefer L Iozzo RV Decoding the matrix: Instructive roles of proteoglycan receptors Biochemistry 54 4583 4598 2015 10.1021/acs.biochem.5b00653 26177309
56 Scherbakov N Knops M Ebner N Valentova M Sandek A Grittner U Dahinden P Hettwer S Schefold JC von Haehling S Evaluation of C-terminal agrin fragment as a marker of muscle wasting in patients after acute stroke during early rehabilitation J Cachexia Sarcopenia Muscle 7 60 67 2016 10.1002/jcsm.12068 27066319
57 Yu D Li HX Liu Y Ying ZW Guo JJ Cao CY Wang J Li YF Yang HR The reference intervals for serum C-terminal agrin fragment in healthy individuals and as a biomarker for renal function in kidney transplant recipients J Clin Lab Anal 31 e22059 2017 10.1002/jcla.22059 27638235
58 Sartori R Hagg A Zampieri S Armani A Winbanks CE Viana LR Haidar M Watt KI Qian H Pezzini C Perturbed BMP signaling and denervation promote muscle wasting in cancer cachexia Sci Transl Med 13 eaay9592 2021 10.1126/scitranslmed.aay9592 34349036
59 Rivera C Zandonadi FS Sanchez-Romero C Soares CD Granato DC Gonzalez-Arriagada WA Paes Leme AF Agrin has a pathological role in the progression of oral cancer Br J Cancer 118 1628 1638 2018 10.1038/s41416-018-0135-5 29872149
60 Bezakova G Ruegg MA New insights into the roles of agrin Nat Rev Mol Cell Biol 4 295 308 2003 10.1038/nrm1074 12671652
61 Sulzmaier FJ Jean C Schlaepfer DD FAK in cancer: Mechanistic findings and clinical applications Nat Rev Cancer 14 598 610 2014 10.1038/nrc3792 25098269
62 Li D Gu Q Xie Z Shen Q Li H Clinical significance of nuclear localisation of agrin in lung adenocarcinoma Pol J Pathol 70 198 204 2019 10.5114/pjp.2019.90396 31820863
63 Zhang QJ Wan L Xu HF High expression of agrin is associated with tumor progression and poor prognosis in hepatocellular carcinoma Math Biosci Eng 16 7375 7383 2019 10.3934/mbe.2019368 31698617
64 Ye P Fu Z Chung JY Cao X Ko H Tian XY Tang PM Lui KO Endothelial agrin is dispensable for normal and tumor angiogenesis Front Cardiovasc Med 8 810477 2022 10.3389/fcvm.2021.810477 35174224
65 Zhu Y Do VD Richards AM Foo R What we know about cardiomyocyte dedifferentiation J Mol Cell Cardiol 152 80 91 2021 10.1016/j.yjmcc.2020.11.016 33275936
66 Porrello ER Mahmoud AI Simpson E Hill JA Richardson JA Olson EN Sadek HA Transient regenerative potential of the neonatal mouse heart Science 331 1078 1080 2011 10.1126/science.1200708 21350179
67 Zlatanova I Sun F Wu RS Chen X Lau BH Colombier P Sinha T Celona B Xu SM Materna SC An injury-responsive mmp14b enhancer is required for heart regeneration Sci Adv 9 eadh5313 2023 10.1126/sciadv.adh5313 38019918
68 Baehr A Umansky KB Bassat E Jurisch V Klett K Bozoglu T Hornaschewitz N Solyanik O Kain D Ferraro B Agrin promotes coordinated therapeutic processes leading to improved cardiac repair in pigs Circulation 142 868 881 2020 10.1161/CIRCULATIONAHA.119.045116 32508131
69 Mazzon C Anselmo A Cibella J Soldani C Destro A Kim N Roncalli M Burden SJ Dustin ML Sarukhan A Viola A The critical role of agrin in the hematopoietic stem cell niche Blood 118 2733 2742 2011 10.1182/blood-2011-01-331272 21653324
70 Burgess RW Dickman DK Nunez L Glass DJ Sanes JR Mapping sites responsible for interactions of agrin with neurons J Neurochem 83 271 284 2002 10.1046/j.1471-4159.2002.01102.x 12423238
71 Guadix JA Orlova VV Giacomelli E Bellin M Ribeiro MC Mummery CL Perez-Pomares JM Passier R Human pluripotent stem cell differentiation into functional epicardial progenitor cells Stem Cell Reports 9 1754 1764 2017 10.1016/j.stemcr.2017.10.023 29173898
72 Germani A Foglio E Capogrossi MC Russo MA Limana F Generation of cardiac progenitor cells through epicardial to mesenchymal transition J Mol Med (Berl) 93 735 748 2015 10.1007/s00109-015-1290-2 25943780
73 Smits AM Dronkers E Goumans MJ The epicardium as a source of multipotent adult cardiac progenitor cells: Their origin, role and fate Pharmacol Res 127 129 140 2018 10.1016/j.phrs.2017.07.020 28751220
74 Jing X Liu B Deng S Du J She Q Agrin yes-associated protein promotes the proliferation of epicardial cells J Cardiovasc Pharmacol 77 94 99 2021 10.1097/FJC.0000000000000926 33136763
75 Sun K Guo J Guo Z Hou L Liu H Hou Y He J Guo F Ye Y The roles of the hippo-YAP signalling pathway in cartilage and osteoarthritis Ageing Res Rev 90 102015 2023 10.1016/j.arr.2023.102015 37454824
76 Hou L Fu W Liu Y Wang Q Wang L Huang Y Agrin promotes limbal stem cell proliferation and corneal wound healing through hippo-yap signaling pathway Invest Ophthalmol Vis Sci 61 7 2020 10.1167/iovs.61.5.7 32392315
77 Manner J Schlueter J Brand T Experimental analyses of the function of the proepicardium using a new microsurgical procedure to induce loss-of-proepicardial-function in chick embryos Dev Dyn 233 1454 1463 2005 10.1002/dvdy.20487 15977171
78 Diman NY Brooks G Kruithof BP Elemento O Seidman JG Seidman CE Basson CT Hatcher CJ Tbx5 is required for avian and mammalian epicardial formation and coronary vasculogenesis Circ Res 115 834 844 2014 10.1161/CIRCRESAHA.115.304379 25245104
79 van Wijk B Gunst QD Moorman AF van den Hoff MJ Cardiac regeneration from activated epicardium PLoS One 7 e44692 2012 10.1371/journal.pone.0044692 23028582
80 Lan Y Pan H Li C Banks KM Sam J Ding B Elemento O Goll MG Evans T TETs regulate proepicardial cell migration through extracellular matrix organization during zebrafish cardiogenesis Cell Rep 26 720 732.e4 2019 10.1016/j.celrep.2018.12.076 30650362
81 Missinato MA Tobita K Romano N Carroll JA Tsang M Extracellular component hyaluronic acid and its receptor Hmmr are required for epicardial EMT during heart regeneration Cardiovasc Res 107 487 498 2015 10.1093/cvr/cvv190 26156497
82 Verzijl N DeGroot J Thorpe SR Bank RA Shaw JN Lyons TJ Bijlsma JW Lafeber FP Baynes JW TeKoppele JM Effect of collagen turnover on the accumulation of advanced glycation end products J Biol Chem 275 39027 39031 2000 10.1074/jbc.M006700200 10976109
83 Erickson CB Hill R Pascablo D Kazakia G Hansen K Bahney C A timeseries analysis of the fracture callus extracellular matrix proteome during bone fracture healing J Life Sci (Westlake Village) 3 1 30 2021 35765657
84 Hausser HJ Ruegg MA Brenner RE Ksiazek I Agrin is highly expressed by chondrocytes and is required for normal growth Histochem Cell Biol 127 363 374 2007 10.1007/s00418-006-0258-2 17186266
85 Campanelli JT Ferns M Hoch W Rupp F von Zastrow M Hall Z Scheller RH Agrin: A synaptic basal lamina protein that regulates development of the neuromuscular junction Cold Spring Harb Symp Quant Biol 57 461 472 1992 10.1101/SQB.1992.057.01.051 1339682
86 Eldridge S Nalesso G Ismail H Vicente-Greco K Kabouridis P Ramachandran M Niemeier A Herz J Pitzalis C Perretti M Dell'Accio F Agrin mediates chondrocyte homeostasis and requires both LRP4 and α-dystroglycan to enhance cartilage formation in vitro and in vivo Ann Rheum Dis 75 1228 1235 2016 10.1136/annrheumdis-2015-207316 26290588
87 Eldridge SE Barawi A Wang H Roelofs AJ Kaneva M Guan Z Lydon H Thomas BL Thorup AS Fernandez BF Agrin induces long-term osteochondral regeneration by supporting repair morphogenesis Sci Transl Med 12 eaax9086 2020 10.1126/scitranslmed.aax9086 32878982
88 Gentili C Cancedda R Cartilage and bone extracellular matrix Curr Pharm Des 15 1334 1348 2009 10.2174/138161209787846739 19355972
89 Grol MW Lee BH Gene therapy for repair and regeneration of bone and cartilage Curr Opin Pharmacol 40 59 66 2018 10.1016/j.coph.2018.03.005 29621661
90 Gomes KDN Alves APNN Dutra PGP Viana GSB Doxycycline induces bone repair and changes in Wnt signalling Int J Oral Sci 9 158 166 2017 10.1038/ijos.2017.28 28960195
91 Bao Q Chen S Qin H Feng J Liu H Liu D Li A Shen Y Zhao Y Li J Zong Z An appropriate Wnt/β-catenin expression level during the remodeling phase is required for improved bone fracture healing in mice Sci Rep 7 2695 2017 10.1038/s41598-017-02705-0 28578392
92 Wang T Zhang X Bikle DD Osteogenic Differentiation of Periosteal Cells During Fracture Healing J Cell Physiol 232 913 921 2017 10.1002/jcp.25641 27731505
93 Ahn Y Sims C Murray MJ Kuhlmann PK Fuentes-Antras J Weatherbee SD Krumlauf R Multiple modes of Lrp4 function in modulation of Wnt/β-catenin signaling during tooth development Development 144 2824 2836 2017 10.1242/dev.150680 28694256
94 Houschyar KS Tapking C Borrelli MR Popp D Duscher D Maan ZN Chelliah MP Li J Harati K Wallner C Wnt pathway in bone repair and regeneration-what do we know so far Front Cell Dev Biol 6 170 2019 10.3389/fcell.2018.00170 30666305
95 Shen C Xiong WC Mei L LRP4 in neuromuscular junction and bone development and diseases Bone 80 101 108 2015 10.1016/j.bone.2015.05.012 26071838
96 Souza ATP Lopes HB Oliveira FS Weffort D Freitas GP Adolpho LF Fernandes RR Rosa AL Beloti MM The extracellular matrix protein Agrin is expressed by osteoblasts and contributes to their differentiation Cell Tissue Res 386 335 347 2021 10.1007/s00441-021-03494-9 34223979
97 Willadt S Nash M Slater C Age-related changes in the structure and function of mammalian neuromuscular junctions Ann N Y Acad Sci 1412 41 53 2018 10.1111/nyas.13521 29291259
98 Taetzsch T Tenga MJ Valdez G Muscle fibers secrete FGFBP1 to slow degeneration of neuromuscular synapses during aging and progression of ALS J Neurosci 37 70 82 2017 10.1523/JNEUROSCI.2992-16.2016 28053031
99 Zhao K Shen C Li L Wu H Xing G Dong Z Jing H Chen W Zhang H Tan Z Sarcoglycan alpha mitigates neuromuscular junction decline in aged mice by stabilizing LRP4 J Neurosci 38 8860 8873 2018 10.1523/JNEUROSCI.0860-18.2018 30171091
100 Samuel MA Valdez G Tapia JC Lichtman JW Sanes JR Agrin and synaptic laminin are required to maintain adult neuromuscular junctions PLoS One 7 e46663 2012 10.1371/journal.pone.0046663 23056392
101 Benjumea AM Curcio CL Duque G Gomez F Dynapenia and sarcopenia as a risk factor for disability in a falls and fractures clinic in older persons Open Access Maced J Med Sci 6 344 349 2018 10.3889/oamjms.2018.087 29531601
102 Zhang X Zhang W Wang C Tao W Dou Q Yang Y Sarcopenia as a predictor of hospitalization among older people: A systematic review and meta-analysis BMC Geriatr 18 188 2018 10.1186/s12877-018-0878-0 30134867
103 Stephan A Mateos JM Kozlov SV Cinelli P Kistler AD Hettwer S Rulicke T Streit P Kunz B Sonderegger P Neurotrypsin cleaves agrin locally at the synapse FASEB J 22 1861 1873 2008 10.1096/fj.07-100008 18230682
104 Kamiya K Tachiki T Sato Y Kouda K Kajita E Tamaki J Kagamimori S Iki M Association between the 110-kDa C-terminal agrin fragment and skeletal muscle decline among community-dwelling older women J Cachexia Sarcopenia Muscle 14 2253 2263 2023 10.1002/jcsm.13309 37562951
105 Drey M Sieber CC Bauer JM Uter W Dahinden P Fariello RG Vrijbloed JW FiAT intervention group C-terminal Agrin Fragment as a potential marker for sarcopenia caused by degeneration of the neuromuscular junction Exp Gerontol 48 76 80 2013 10.1016/j.exger.2012.05.021 22683512
106 Racha P Selvam S Bose B Bantwal G Sambashivaiah S Circulating C-terminal agrin fragment: A potential marker for sarcopenia among type 2 diabetes Indian J Endocrinol Metab 26 334 340 2022 10.4103/ijem.ijem_507_21 36185967
107 Pratt J De Vito G Narici M Segurado R Pessanha L Dolan J Conroy J Boreham C Plasma C-terminal agrin fragment as an early biomarker for sarcopenia: Results from the GenoFit study J Gerontol A Biol Sci Med Sci 76 2090 2096 2021 10.1093/gerona/glab139 33993303
108 Denzer AJ Brandenberger R Gesemann M Chiquet M Ruegg MA Agrin binds to the nerve-muscle basal lamina via laminin J Cell Biol 137 671 683 1997 10.1083/jcb.137.3.671 9151673
109 Denzer AJ Schulthess T Fauser C Schumacher B Kammerer RA Engel J Ruegg MA Electron microscopic structure of agrin and mapping of its binding site in laminin-1 EMBO J 17 335 343 1998 10.1093/emboj/17.2.335 9430625
110 Raats CJ van den Born J Bakker MA Oppers-Walgreen B Pisa BJ Dijkman HB Assmann KJ Berden JH Expression of agrin, dystroglycan, and utrophin in normal renal tissue and in experimental glomerulopathies Am J Pathol 156 1749 1765 2000 10.1016/S0002-9440(10)65046-8 10793086
111 Goldberg S Harvey SJ Cunningham J Tryggvason K Miner JH Glomerular filtration is normal in the absence of both agrin and perlecan-heparan sulfate from the glomerular basement membrane Nephrol Dial Transplant 24 2044 2051 2009 10.1093/ndt/gfn758 19144998
112 Harvey SJ Jarad G Cunningham J Rops AL van der Vlag J Berden JH Moeller MJ Holzman LB Burgess RW Miner JH Disruption of glomerular basement membrane charge through podocyte-specific mutation of agrin does not alter glomerular permselectivity Am J Pathol 171 139 152 2007 10.2353/ajpath.2007.061116 17591961
113 Vestentoft PS Jelnes P Andersen JB Tran TA Jorgensen T Rasmussen M Bornholdt J Grovdal LM Jensen CH Vogel LK Molecular constituents of the extracellular matrix in rat liver mounting a hepatic progenitor cell response for tissue repair Fibrogenesis Tissue Repair 6 21 2013 10.1186/1755-1536-6-21 24359594
114 Deng SX Borderie V Chan CC Dana R Figueiredo FC Gomes JAP Pellegrini G Shimmura S Kruse FE The International Limbal Stem Cell Deficiency Working Group Global consensus on definition, classification, diagnosis, and staging of limbal stem cell deficiency Cornea 38 364 375 2019 10.1097/ICO.0000000000001820 30614902
115 Kolli S Ahmad S Lako M Figueiredo F Successful clinical implementation of corneal epithelial stem cell therapy for treatment of unilateral limbal stem cell deficiency Stem Cells 28 597 610 2010 10.1002/stem.276 20014040
116 Whitcher JP Srinivasan M Upadhyay MP Corneal blindness: A global perspective Bull World Health Organ 79 214 221 2001 11285665
117 Sacchetti M Rama P Bruscolini A Lambiase A Limbal stem cell transplantation: Clinical results, limits, and perspectives Stem Cells Int 2018 8086269 2018 10.1155/2018/8086269 30405723
118 Ribatti D d'Amati A Hematopoiesis and Mast Cell Development Int J Mol Sci 24 10679 2023 10.3390/ijms241310679 37445862
119 Bruno E Luikart SD Long MW Hoffman R Marrow-derived heparan sulfate proteoglycan mediates the adhesion of hematopoietic progenitor cells to cytokines Exp Hematol 23 1212 1217 1995 7556532
120 Sorg H Sorg CGG Skin wound healing: Of players, patterns, and processes Eur Surg Res 64 141 157 2023 10.1159/000528271 36417847
121 Xue M Jackson CJ Extracellular matrix reorganization during wound healing and its impact on abnormal scarring Adv Wound Care (New Rochelle) 4 119 136 2015 10.1089/wound.2013.0485 25785236
122 Chakraborty S Sampath D Yu Lin MO Bilton M Huang CK Nai MH Njah K Goy PA Wang CC Guccione E Agrin-matrix metalloproteinase-12 axis confers a mechanically competent microenvironment in skin wound healing Nat Commun 12 6349 2021 10.1038/s41467-021-26717-7 34732729
123 Yu Lin MO Sampath D Bosykh DA Wang C Wang X Subramaniam T Han W Hong W Chakraborty S YAP/TAZ drive agrin-matrix metalloproteinase-12 mediated diabetic skin wound healing J Invest Dermatol May 27 2024 Epub ahead of print 10.1016/j.jid.2024.05.005
124 Calvo F Ege N Grande-Garcia A Hooper S Jenkins RP Chaudhry SI Harrington K Williamson P Moeendarbary E Charras G Sahai E Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts Nat Cell Biol 637 646 2013 10.1038/ncb2756 23708000
125 Sun X Malandraki-Miller S Kennedy T Bassat E Klaourakis K Zhao J Gamen E Vieira JM Tzahor E Riley PR The extracellular matrix protein agrin is essential for epicardial epithelial-to-mesenchymal transition during heart development Development 148 dev197525 2021 10.1242/dev.197525 33969874
